Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - NetReceivables - OtherShares Repurchased
Ratios

Caris Life Sciences (CAI) Shares Repurchased (2025)

Caris Life Sciences has reported Shares Repurchased over the past 1 years, most recently at $91000.0 for Q4 2025.

  • Quarterly results put Shares Repurchased at $91000.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $91000.0 (changed N/A YoY), and the annual figure for FY2025 was $113000.0, changed.
  • Shares Repurchased for Q4 2025 was $91000.0 at Caris Life Sciences.
  • Over the last five years, Shares Repurchased for CAI hit a ceiling of $91000.0 in Q4 2025 and a floor of $91000.0 in Q4 2025.